Mecure Industries PLC (NGX:MECURE)

Nigeria flag Nigeria · Delayed Price · Currency is NGN
104.00
0.00 (0.00%)
At close: Jan 29, 2026
648.20%
Market Cap416.00B
Revenue (ttm)75.82B +87.7%
Net Income5.23B +110.5%
EPS1.31 +111.5%
Shares Out4.00B
PE Ratio79.55
Forward PEn/a
Dividend0.15 (0.14%)
Ex-Dividend DateApr 22, 2025
Volume250,554
Average Volume744,220
Openn/a
Previous Close104.00
Day's Rangen/a
52-Week Range11.10 - 104.00
Beta0.42
RSI99.77
Earnings DateFeb 26, 2026

About Mecure Industries

Mecure Industries PLC manufactures and sells pharmaceuticals in Nigeria. The company also engages in distributing multivitamins products. In addition, it offers antibiotics, antimalarials, antihypertensives, antidiabetics, analgesics and nsaids, proton pump inhibitors, and H2 receptor antagonists. Further, it provides blood tonics; cough, cold, and catarrh preparations; antihistamines; anthelmintic; antacids; steroids; antispasmodics; and antidiarrheals. Additionally, it involved in the contract manufacturing services. It sells its products thr... [Read more]

Industry Pharmaceutical Preparations
Founded 2005
Employees 192
Stock Exchange Nigerian Stock Exchange
Ticker Symbol MECURE
Full Company Profile

Financial Performance

In 2024, Mecure Industries's revenue was 46.03 billion, an increase of 44.92% compared to the previous year's 31.76 billion. Earnings were 2.33 billion, a decrease of -20.07%.

Financial Statements